Oral tacrolimus noninferior to intravenous cyclophosphamide for lupus nephritis
1. Oral tacrolimus was noninferior to intravenous cyclophosphamide for lupus nephritis disease measures with lower toxicity. Evidence Rating Level: 1...
1. Oral tacrolimus was noninferior to intravenous cyclophosphamide for lupus nephritis disease measures with lower toxicity. Evidence Rating Level: 1...
1. Rilzabrutinib was active and 400mg twice daily was identified as the dose for further testing with low-level toxic effects....
1. In utero exposure to any maternal autoimmune disease was associated with increased risks of overall and type-specific mental disorders...
1. There were no differences in the risk of Alzheimer disease and related dementia in patients with rheumatoid arthritis treated...
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema attacks compared to patients receiving placebo treatment. 2....
1. More patients with systemic lupus erythematosus (SLE) who received high doses of iberdomide achieved SRI-4 response compared to placebo...
1. In a systematic review of 74 studies reporting Kawasaki disease (KD) outcomes over years of follow-up, overall mortality estimates...
1. In patients with gout and chronic kidney disease, the initiation of allopurinol was not associated with increased mortality. 2....
1. Patients with rheumatoid arthritis (RA) treated with tofacitinib showed a higher risk of developing major adverse cardiovascular events and...
1. There was a dose-related decrease in disease activity from baseline to 24-weeks for patients on ianalumab compared to placebo....
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.